Status:
COMPLETED
Prospective Randomized Controlled Study of Intravitreal Injection of Bevacizumab for Proliferative Diabetic Retinopathy
Lead Sponsor:
Nihon University
Conditions:
Proliferative Diabetic Retinopathy
Diabetic Traction Retinal Detachment
Eligibility:
All Genders
Phase:
PHASE4
Brief Summary
We hypothesized that to reduce the adverse effects of intravitreal bevacizumab on ocular tissue and whole body, intravitreal injection of a low concentration of bevacizumab and conducting vitrectomy s...
Detailed Description
Early postoperative hemorrhage in proliferative diabetic retinopathy (PDR) patients is a major complication. Intravitreal injection of anti-vascular endothelial growth factor (VEGF) has reported to re...
Eligibility Criteria
Inclusion
- Clinical diagnosis of Proliferative Diabetic Retinopathy (PDR)
- Indicated for vitrectomy
Exclusion
- History of intraocular surgery, intravitreal injection of drugs or sub-Tenon injection of steroids or retinal photocoagulation within 6 months
Key Trial Info
Start Date :
May 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2014
Estimated Enrollment :
69 Patients enrolled
Trial Details
Trial ID
NCT01854593
Start Date
May 1 2012
End Date
March 1 2014
Last Update
July 14 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Surugadai Nihon University Hospital
Tokyo, Japan, 101-8309